Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leukaemic myeloid and lymphoid cell N-acetyl beta-D glucosaminidase (hexosaminidase) enzymes were fractionated by Fast Protein Liquid Chromatography (FPLC) using high-resolution ion exchange (Mono-S and Mono-Q), gel filtration (Superose-6) and chromatofocusing (Mono-P) columns. Although only one molecular weight species was detected in haemopoietic cells, with an apparent mass of 129 kD, "isoenzyme" variants defined by differences in molecular charge were considerably more diverse than previously thought. Separation of the major Hex forms (A and B) by chromatofocusing indicated that intermediate (I) components were present in most acute leukaemias irrespective of lineage supporting the concept that the I form is a non-specific marker of haemopoietic
immaturity
. Substrate and inhibitor studies further revealed that leukaemic cell hexosaminidases hydrolyse galactopyranosides at significantly lower rates than glucopyranosides and that the hydrolysis of N-acetyl beta-D
glucosamine
is inhibited by both
glucosamine
and galactosamine products.
...
PMID:Fast protein liquid chromatography (FPLC) of leukaemic cell N-acetyl beta-D hexosaminidases. 347 15
Mucin secretion was examined in three functional models relevant to human disease, using rat small intestinal rings or in situ loops, [3H]
glucosamine
precursor labelling, gel chromatography and a specific radioimmunoassay for mucin. As a model for acute bacterial secretory diarrhoea, tissues were exposed to cholera toxin for up to 4 h. Both stored and newly synthesized radioactive glycoproteins were secreted in amounts twofold to threefold above control levels. Immunoreactive mucin secretion increased fivefold to eightfold. Other agents known to raise cAMP levels did not stimulate mucin secretion, suggesting that cholera may release mucin by a non-cAMP-dependent mechanism. Sepharose 2B chromatography indicated that secreted mucin was smaller in size than intracellular mucin and had compositional differences suggestive of '
immaturity
' or protein contamination. In chronically (seven days) reserpinized rats, used as a model of glycoprotein abnormalities relevant to cystic fibrosis, mucin secretion increased twofold to threefold, but the most prominent abnormality was a marked increase in [3H]
glucosamine
incorporation into all tissue glycoproteins. On purification, the intracellular mucin of reserpine-treated rats had the same composition as mucin from control rats, but the former was smaller in size and had a higher specific radioactivity. Mucin hypersecretion in reserpinized rats may therefore be secondary to a primary and chronic hyperstimulation of mucin biosynthesis. A model of intestinal 'anaphylaxis' or immune-mediated diarrhoea was created in Hooded Lister rats by immunizing with egg albumin (10 micrograms) and challenging with the same antigen in intestinal loops 14 days later. After 4 h, total protein, DNA and brush border sucrase were increased in the lumen. Enhancement of mucin secretion did not occur, however, and therefore does not seem to be a particular feature of the pathophysiology of this model.
...
PMID:Acute and chronic models for hypersecretion of intestinal mucin. 656 39